Home › Compare › MDAV vs JNJ

MDAV vs JNJ: Dividend Comparison 2026

MDAV yields 1000000.00% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MDAV wins by $4.7683925249533696e+36M in total portfolio value
10 years
MDAV
MDAV
● Live price
1000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.7683925249533696e+36M
Annual income
$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00
Full MDAV calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — MDAV vs JNJ

📍 MDAV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMDAVJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MDAV + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
MDAV pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MDAV
Annual income on $10K today (after 15% tax)
$85,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, MDAV beats the other by $4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MDAV + JNJ for your $10,000?

MDAV: 50%JNJ: 50%
100% JNJ50/50100% MDAV
Portfolio after 10yr
$2.3841962624766848e+36M
Annual income
$2,383,727,347,228,033,600,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.98%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

MDAV
No analyst data
Altman Z
-6.3
Piotroski
1/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MDAV buys
0
JNJ buys
0
No recent congressional trades found for MDAV or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMDAVJNJ
Forward yield1000000.00% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$4.7683925249533696e+36M$20.0K ✓
Annual income after 10y$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00 ✓$827.78
Total dividends collected$4.7683311610149396e+36M$5.6K ✓
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: MDAV vs JNJ ($10,000, DRIP)

YearMDAV PortfolioMDAV Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$100,010,700$100,000,000.00$10,676$355.77+$100.00M → MDAV
2$934,786,450,701$934,679,439,252.34$11,407$389.39+$934786.44M → MDAV
3$8,165,787,108,578,292$8,164,786,887,076,042.00$12,198$426.53+$8165787108.57M → MDAV
4$66,665,884,190,957,650,000$66,657,146,798,751,470,000.00$13,056$467.62+$66665884190957.63M → MDAV
5$508,662,171,058,048,100,000,000$508,590,838,561,963,700,000,000.00$13,987$513.12+$508662171058048128.00M → MDAV
6$3,627,235,248,428,489,700,000,000,000$3,626,690,979,905,457,600,000,000,000.00$14,998$563.56+$3.62723524842849e+21M → MDAV
7$24,173,681,159,150,610,000,000,000,000,000$24,169,800,017,434,790,000,000,000,000,000.00$16,098$619.52+$2.417368115915061e+25M → MDAV
8$150,567,402,861,454,640,000,000,000,000,000,000$150,541,537,022,614,370,000,000,000,000,000,000.00$17,295$681.69+$1.5056740286145463e+29M → MDAV
9$876,477,100,281,847,600,000,000,000,000,000,000,000$876,315,993,160,785,800,000,000,000,000,000,000,000.00$18,599$750.82+$8.764771002818475e+32M → MDAV
10$4,768,392,524,953,369,600,000,000,000,000,000,000,000,000$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00$20,022$827.78+$4.7683925249533696e+36M → MDAV

MDAV vs JNJ: Complete Analysis 2026

MDAV — Stock

Davi Luxury Brand Group, Inc. develops and markets a line of skin care/cosmetic products based on grape and botanical-based luxury branded skin care products for women and men under the Davi, Davi Skin, and Davi Napa brand names. The company offers skin care, cosmetics, hair care, and other products. It provides approximately 30 Davi branded products of which approximately 20 are sold through its daviskin.com Website. The company's target customers include retail stores, luxury hotels, and in-flight and duty-free shops. The company was formerly known as Dafoe Corp. and changed its name to Davi Luxury Brand Group, Inc. in January 2011. Davi Luxury Brand Group, Inc. was founded in 2007 and is headquartered in Beverly Hills, California.

Full MDAV Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this MDAV vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MDAV vs SCHDMDAV vs JEPIMDAV vs OMDAV vs KOMDAV vs MAINMDAV vs ABBVMDAV vs MRKMDAV vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.